Showing results (81-90 of 86) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2018
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohortShubha S Bellur, Ian S D Roberts, Stéphan Troyanov, et al.Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.Pediatric Nephrology (Berlin, Germany)|August 26, 2016
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Danilo Lofaro, Roberta R Camilla, et al.The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 13, 2018
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) updateRosanna Coppo, Graziella D'Arrigo, Giovanni Tripepi, et al.Nature Communications|April 2, 2020
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosisJingyuan Xie, Lili Liu, Nikol Mladkova, et al.Pageof 9